A power outage in 1957 sparked the birth of the modern medical device giant.

A power outage in 1957 sparked the birth of the modern medical device giant.
Image: Intellect (generated)

In short: When a Minnesota blackout caused the death of a child dependent on a pacemaker, a local repairman named Earl Bakken was challenged to innovate. He transformed a transistorized metronome into the first battery-powered external pacemaker, launching a company that now leads the world in medical technology and life-saving therapies.

Founded in 1949 as a simple repair shop, Medtronic evolved into a global powerhouse through a series of technical breakthroughs and aggressive acquisitions. The company’s trajectory changed permanently in 1957, when Bakken collaborated with heart surgeon C. Walton Lillehei to solve the fatal limitations of existing pacemakers. This partnership established the company’s core focus on cardiac rhythm management, a field where it remains a dominant force today, having expanded its expertise to include implantable cardioverter-defibrillators and remote monitoring systems.

The company’s growth strategy has relied heavily on strategic expansion. In 2015, Medtronic completed a massive acquisition of Covidien, a move that shifted its legal headquarters to Ireland in a high-profile tax inversion. This deal solidified its status as the world’s largest medical device company by revenue. Beyond cardiac care, the firm has diversified into spinal therapies, neuromodulation, and diabetes management, notably launching the world’s first hybrid closed-loop insulin delivery system in 2017.

However, this rapid expansion has not been without controversy or risk. The company has faced significant legal and ethical scrutiny, including a 2008 settlement regarding allegations of Medicare fraud related to spinal surgery procedures. Furthermore, its reliance on complex, connected medical devices has introduced new vulnerabilities; researchers have demonstrated that some of its insulin pumps and cardiac implants could be compromised by unauthorized remote access. These incidents highlight the tension between the life-saving potential of digitized healthcare and the persistent safety challenges inherent in managing millions of interconnected, high-stakes medical devices.

Today, Medtronic operates in over 150 countries with a workforce exceeding 90,000 employees. While it continues to push the boundaries of surgical robotics and AI-powered analytics, the company remains a lightning rod for debates regarding corporate governance, tax structures, and the reliability of its long-term medical hardware, such as the ongoing disputes surrounding the failure rates of its Sprint Fidelis leads.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/wealth-medtronic.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…